101 related articles for article (PubMed ID: 7917220)
1. Serum antibodies from MS patients do not recognize HTLV-I, HIV-1, HIV-2 and SIV.
Brokstad KA; Kalland KH; Page M; Nyland H; Haaheim L
APMIS; 1994 Jul; 102(7):514-20. PubMed ID: 7917220
[TBL] [Abstract][Full Text] [Related]
2. Seroreactivity to human T cell leukemia/lymphoma virus type 1 and related retroviruses in multiple sclerosis patients from Denmark and the Faroes.
Rasmussen HB; Kvinesdal BB; Clausen J
Acta Neurol Scand; 1992 Jul; 86(1):91-4. PubMed ID: 1325731
[TBL] [Abstract][Full Text] [Related]
3. Identification of regions of HIV-1 p24 reactive with sera which give "indeterminate" results in electrophoretic immunoblots with the help of long synthetic peptides.
Blomberg J; Vincic E; Jönsson C; Medstrand P; Pipkorn R
AIDS Res Hum Retroviruses; 1990 Dec; 6(12):1363-72. PubMed ID: 2127683
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies to conserved regions of the major core protein (gag24) of HIV-1 and HIV-2.
Carpio E; Duarte C; Hinkula J; Broliden PA; Rosén J; Campal A; Gavilondo J; Wahren B; Jondal M
AIDS Res Hum Retroviruses; 1991 Jan; 7(1):97-101. PubMed ID: 1707645
[TBL] [Abstract][Full Text] [Related]
5. Cross-reactivity with SIVmac in east African HIV-1-positive sera: evidence against double infection with HIV-1 and a SIVmac/HIV-2-like virus.
Blomberg J; Klasse PJ; Pehrson C
Intervirology; 1990; 31(5):276-84. PubMed ID: 1703133
[TBL] [Abstract][Full Text] [Related]
6. Evidence of serological cross-reactivities with human immunodeficiency virus types 1 and 2 and human T-lymphotropic virus types I and II in sera of pregnant women in Ibadan, Nigeria.
Olaleye DO; Ekweozor CC; Sheng Z; Rasheed S
Int J Epidemiol; 1995 Feb; 24(1):198-203. PubMed ID: 7797344
[TBL] [Abstract][Full Text] [Related]
7. Site-directed enzyme-linked immunosorbent assay with a synthetic simian immunodeficiency virus SIVmac peptide identifying antibodies against the HIV-2 transmembrane glycoprotein.
Norrby E; Chiodi F; Whalley A; Parks E; Nauclér A; Costa CM; Torstensson R; Biberfeld G
AIDS; 1989 Jan; 3(1):17-20. PubMed ID: 2469436
[TBL] [Abstract][Full Text] [Related]
8. Antibody to reverse transcriptase of human retroviruses in multiple sclerosis.
Perron H; Geny C; Genoulaz O; Pellat J; Perret J; Seigneurin JM
Acta Neurol Scand; 1991 Dec; 84(6):507-13. PubMed ID: 1724334
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
[TBL] [Abstract][Full Text] [Related]
10. SIV, STLV-I and type D retrovirus antibodies in captive rhesus macaques and immunoblot reactivity to SIV p27 in human and rhesus monkey sera.
Lairmore MD; Lerche NW; Schultz KT; Stone CM; Brown BG; Hermann LM; Yee JA; Jennings M
AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1233-8. PubMed ID: 1706606
[TBL] [Abstract][Full Text] [Related]
11. Conserved immunogenic region of a major core protein (p24) of human and simian immunodeficiency viruses.
Koito A; Hattori T; Matsushita S; Maeda Y; Nozaki C; Sagawa K; Takatsuki K
AIDS Res Hum Retroviruses; 1988 Dec; 4(6):409-17. PubMed ID: 2464360
[TBL] [Abstract][Full Text] [Related]
12. Antigenic relatedness between ovine progressive pneumonia virus (OPPV) and HIV-1.
Maslak DM; Schmerr MJ
Comp Immunol Microbiol Infect Dis; 1993 Apr; 16(2):103-11. PubMed ID: 8391410
[TBL] [Abstract][Full Text] [Related]
13. Characterization of murine monoclonal antibodies directed against the core proteins of human immunodeficiency virus types 1 and 2.
Niedrig M; Hinkula J; Harthus HP; Bröker M; Hopp L; Pauli G; Wahren B
J Virol; 1991 Aug; 65(8):4529-33. PubMed ID: 1712863
[TBL] [Abstract][Full Text] [Related]
14. Detection of serum antibodies in Ethiopian baboons that cross-react with SIV, HTLV-I, and type D retroviral antigens.
Benveniste RE; Hill RW; Knott WB; Tsai CC; Kuller L; Morton WR
J Med Primatol; 1993; 22(2-3):124-8. PubMed ID: 8411104
[TBL] [Abstract][Full Text] [Related]
15. Conserved epitopes on HIV-1, FIV and SIV p24 proteins are recognized by HIV-1 infected subjects.
Roff SR; Sanou MP; Rathore MH; Levy JA; Yamamoto JK
Hum Vaccin Immunother; 2015; 11(6):1540-56. PubMed ID: 25844718
[TBL] [Abstract][Full Text] [Related]
16. Detection of simian immunodeficiency virus and human immunodeficiency virus type 2 capsid antigens by a monoclonal antibody-based antigen capture assay.
Lairmore MD; Hofheinz DE; Letvin NL; Stoner CS; Pearlman S; Toedter GP
AIDS Res Hum Retroviruses; 1993 Jun; 9(6):565-71. PubMed ID: 7688521
[TBL] [Abstract][Full Text] [Related]
17. The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1.
Javaherian K; Langlois AJ; Schmidt S; Kaufmann M; Cates N; Langedijk JP; Meloen RH; Desrosiers RC; Burns DP; Bolognesi DP
Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1418-22. PubMed ID: 1371358
[TBL] [Abstract][Full Text] [Related]
18. Antibody-dependent cellular cytotoxicity detects type- and strain-specific antigens among human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus SIVmac isolates.
Ljunggren K; Biberfeld G; Jondal M; Fenyö EM
J Virol; 1989 Aug; 63(8):3376-81. PubMed ID: 2746734
[TBL] [Abstract][Full Text] [Related]
19. Sera from patients with multiple sclerosis react with human cell T lymphotropic virus-I gag proteins but not env proteins--Western blotting analysis.
Ohta M; Ohta K; Mori F; Nishitani H; Saida T
J Immunol; 1986 Dec; 137(11):3440-3. PubMed ID: 3023483
[TBL] [Abstract][Full Text] [Related]
20. An ELISA-inhibition assay for antibody to human immunodeficiency virus core antigen (p24).
Povolotsky J; Gold JW; Darminin P; Chein N; Baron P; Armstrong D
J Virol Methods; 1990 Oct; 30(1):109-14. PubMed ID: 2128300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
